Oncotarget is an oncology-focused, peer-reviewed, open access journal founded in 2010. It covers research on all aspects of oncology and is indexed by MEDLINE/PubMed and PMC/PubMed. The journal publishes papers continuously within yearly volumes and releases them quickly to PubMed. Oncotarget is based in the United States and operates in the biotechnology, health care, and publishing industries. Currently, there is no publicly available information regarding its last investment or investors. To ensure scientific integrity, the company has implemented a rigorous process outlined on their website.
Oncotarget
Oncotarget is a peer-reviewed, open-access biomedical journal covering research on all aspects of oncology
Founded 2010
Orchard Park, United States
9 employees
Biotechnology, Health Care +1
Orchard Park, United States
9 employees
Biotechnology, Health Care +1
General Information
Company Name
Oncotarget
Founded Year
2010
Location
Orchard Park, United States
Orchard Park, United States
Employees
9
Industries
Biotechnology, Health Care, Publishing
Social
BounceWatch is an independent company data service, not affiliated with Oncotarget. To contact Oncotarget, visit oncotarget.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Oncotarget compare?
A PDF of Oncotarget and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Oncotarget soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Oncotarget on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United States Market
Biotechnology
About Oncotarget
Business keywords: Oncology, Cancer Research, Biomedical Journal, Open Access Publishing, Peer-Review, MEDLINE, PMC, Scientific Integrity, Hematology, Tumor Research
No funding data available for Oncotarget yet.
Oncotarget Alternatives & Competitors
View All Alternatives
Oncotarget vs
Oncotarget vs
Forty Seven Inc.
United States
Helping Patients Defeat Their Cancer
Post-IPO Equity
17 employees
Biotechnology, Health Care
Oncotarget vs
Cureus Journal of Medical Science
United States
An innovative, more efficient platform for clinicians and researchers to publish and share research.
627 employees
Health Care, Publishing
FAQ About Oncotarget
Oncotarget is a peer-reviewed, open-access biomedical journal covering research on all aspects of oncology
Oncotarget was founded in 2010.
Oncotarget is headquartered in Orchard Park, United States.
Oncotarget operates in Biotechnology, Health Care and Publishing. Its work centres on Oncology, Cancer Research, Biomedical Journal and Open Access Publishing.
Oncotarget has approximately 9 employees.
Top alternatives and competitors to Oncotarget include Crimson Publishers, Forty Seven Inc., Cureus Journal of Medical Science, Genus Oncology LLC, Acomhal Research, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Oncotarget and Crimson Publishers are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Oncotarget, https://bouncewatch.com/company/oncotarget, updated 5 January 2025. When citing, please name BounceWatch and link this page.
